• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[某种疾病]中碳青霉烯类耐药性的出现是否会增加病死率?系统评价与Meta分析。

Does Emerging Carbapenem Resistance in Increase the Case Fatality Rate? Systematic Review and Meta-Analysis.

作者信息

Boral Jale, Pınarlık Fatihan, Ekinci Güz, Can Füsun, Ergönül Önder

机构信息

Graduate School of Health Sciences, Koç University, Istanbul 34010, Türkiye.

Koç University İşBank Center for Infectious Diseases, Koç University Hospital (KUISCID), Istanbul 34010, Türkiye.

出版信息

Infect Dis Rep. 2023 Sep 27;15(5):564-575. doi: 10.3390/idr15050055.

DOI:10.3390/idr15050055
PMID:37888136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10606343/
Abstract

BACKGROUND

In the era of rising carbapenem resistance, we aimed to investigate the change in mortality rate and positivity of carbapenemase genes in .

METHODS

Preferred Reporting Items for Systematic Review (PRISMA) guidelines were adopted in this systematic review. Our literature search included the Cochrane Library, Pubmed, Scopus, Web of Science, Medline, Tubitak TR Dizin, and Harman databases for studies dating back from 2003 to 2023 reporting bloodstream infections in Türkiye. A simple linear regression model was used to determine the association between resistance, mortality, and time.

RESULTS

A total of 1717 studies were identified through a literature search, and 21 articles were selected based on the availability of the data regarding mortality and resistance rate (four articles) or the molecular epidemiology of carbapenem-resistant (17 articles) in Türkiye. From 2007 to 2018, the carbapenem resistance rate increased ( = 0.025). The OXA-23 and OXA-58 positivities were inversely correlated ( = 0.025).

CONCLUSIONS

Despite the emergence of carbapenem resistance, mortality did not increase in parallel, which may be due to improved medical advancements or the fitness cost of bacteria upon prolonged antimicrobial exposure. Therefore, we suggest further global research with the foresight to assess clonal relatedness that might affect the carbapenem resistance rate.

摘要

背景

在碳青霉烯耐药性不断上升的时代,我们旨在调查[具体对象]中死亡率的变化以及碳青霉烯酶基因的阳性率。

方法

本系统评价采用系统评价的首选报告项目(PRISMA)指南。我们的文献检索包括Cochrane图书馆、PubMed、Scopus、科学网、Medline、Tubitak TR Dizin和Harman数据库,以查找2003年至2023年期间报告土耳其血流感染情况的研究。使用简单线性回归模型来确定耐药性、死亡率和时间之间的关联。

结果

通过文献检索共识别出1717项研究,根据土耳其关于死亡率和耐药率的数据(4篇文章)或耐碳青霉烯类的分子流行病学(17篇文章)的可得性,选择了21篇文章。从2007年到2018年,碳青霉烯耐药率上升(=0.025)。OXA-23和OXA-58阳性率呈负相关(=0.025)。

结论

尽管出现了碳青霉烯耐药性,但死亡率并未随之上升,这可能是由于医疗进步或细菌在长期接触抗菌药物后的适应性代价。因此,我们建议进行进一步的全球研究,前瞻性地评估可能影响碳青霉烯耐药率的克隆相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/10606343/71e106a0ce10/idr-15-00055-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/10606343/9fba082540e7/idr-15-00055-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/10606343/8691907cbd24/idr-15-00055-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/10606343/71e106a0ce10/idr-15-00055-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/10606343/9fba082540e7/idr-15-00055-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/10606343/8691907cbd24/idr-15-00055-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/10606343/71e106a0ce10/idr-15-00055-g003.jpg

相似文献

1
Does Emerging Carbapenem Resistance in Increase the Case Fatality Rate? Systematic Review and Meta-Analysis.[某种疾病]中碳青霉烯类耐药性的出现是否会增加病死率?系统评价与Meta分析。
Infect Dis Rep. 2023 Sep 27;15(5):564-575. doi: 10.3390/idr15050055.
2
Epidemiology and mortality outcome of carbapenem- and colistin-resistant , and bloodstream infections.碳青霉烯类和黏菌素耐药菌以及血流感染的流行病学和死亡率结果
IJID Reg. 2023 Jan 8;7:1-5. doi: 10.1016/j.ijregi.2023.01.002. eCollection 2023 Jun.
3
Carbapenamase-Producing Acinetobacter baumannii in China, Latin America and the Caribbean.中国、拉丁美洲和加勒比地区产碳青霉烯酶鲍曼不动杆菌。
MEDICC Rev. 2022 Jan 31;24(1):59-69. doi: 10.37757/MR2022.V24.N1.8.
4
Healthcare-associated carbapenem-resistant OXA-72-producing Acinetobacter baumannii of the clonal complex CC79 colonizing migratory and captive aquatic birds in a Brazilian Zoo.巴西一动物园中迁徙和圈养水禽携带的克隆复合体 CC79 型碳青霉烯类耐药鲍曼不动杆菌 OXA-72 型 请注意,我给出的译文可能会根据具体语境和用词习惯有所不同,你可以根据自己的需求进行调整。
Sci Total Environ. 2020 Jul 15;726:138232. doi: 10.1016/j.scitotenv.2020.138232. Epub 2020 Mar 26.
5
Carbapenem-resistant Acinetobacter baumannii in patients with burn injury: A systematic review and meta-analysis.烧伤患者中耐碳青霉烯鲍曼不动杆菌的研究:系统评价和荟萃分析。
Burns. 2019 Nov;45(7):1495-1508. doi: 10.1016/j.burns.2019.07.006. Epub 2019 Jul 25.
6
Clonal spread of carbapenem resistant Acinetobacter baumannii ST92 in a Chinese Hospital during a 6-year period.6 年间中国某医院耐碳青霉烯鲍曼不动杆菌 ST92 的克隆传播
J Microbiol. 2013 Feb;51(1):113-7. doi: 10.1007/s12275-013-2341-4. Epub 2013 Mar 2.
7
[Molecular epidemiological characteristics of clinically isolated carbapenem-resistant Acinetobacter baumannii in Changsha].[长沙临床分离的耐碳青霉烯鲍曼不动杆菌分子流行病学特征]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012 May;37(5):521-6. doi: 10.3969/j.issn.1672-7347.2012.05.018.
8
Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in Italy.意大利耐碳青霉烯鲍曼不动杆菌的分子流行病学研究。
Ann Ig. 2021 Sep-Oct;33(5):401-409. doi: 10.7416/ai.2020.2395. Epub 2020 Dec 4.
9
Prevalence of different carbapenemase genes among carbapenem-resistant blood isolates in Taiwan.台湾血源分离碳青霉烯耐药菌中不同碳青霉烯酶基因的流行率。
Antimicrob Resist Infect Control. 2018 Oct 11;7:123. doi: 10.1186/s13756-018-0410-5. eCollection 2018.
10
Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China.广泛分布的碳青霉烯类耐药和产 OXA-23 的鲍曼不动杆菌在中国多个省份。
Int J Antimicrob Agents. 2013 Oct;42(4):322-8. doi: 10.1016/j.ijantimicag.2013.06.019. Epub 2013 Aug 9.

引用本文的文献

1
Molecular Epidemiology and Genetic Characterization of Carbapenem-Resistant Isolates from the ICU of a Tertiary Hospital in East China.中国东部一家三级医院重症监护病房耐碳青霉烯类分离株的分子流行病学及基因特征分析
Infect Drug Resist. 2024 Dec 31;17:5925-5945. doi: 10.2147/IDR.S491858. eCollection 2024.
2
Geographical mapping and temporal trends of Acinetobacter baumannii carbapenem resistance: A comprehensive meta-analysis.鲍曼不动杆菌对碳青霉烯类耐药的地理分布及时间趋势:一项综合荟萃分析。
PLoS One. 2024 Dec 16;19(12):e0311124. doi: 10.1371/journal.pone.0311124. eCollection 2024.
3
An overview of sulbactam-durlobactam approval and implications in advancing therapeutics for hospital-acquired and ventilator-associated pneumonia by complex: A narrative review.

本文引用的文献

1
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians.如何在床边使用感染或脓毒症的生物标志物:临床医生指南。
Intensive Care Med. 2023 Feb;49(2):142-153. doi: 10.1007/s00134-022-06956-y. Epub 2023 Jan 2.
2
The association between Acinetobacter baumannii infections and the COVID-19 pandemic in an intensive care unit.鲍曼不动杆菌感染与重症监护病房 COVID-19 大流行之间的关联。
Sci Rep. 2022 Dec 2;12(1):20808. doi: 10.1038/s41598-022-25493-8.
3
Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
舒巴坦-度洛巴坦获批情况概述及其对推进医院获得性肺炎和呼吸机相关性肺炎治疗方案的影响:一项叙述性综述。
Health Sci Rep. 2024 Sep 9;7(9):e70066. doi: 10.1002/hsr2.70066. eCollection 2024 Sep.
4
Resensitization to colistin results in rapid and stable recovery of adherence, serum resistance and ompW in Acinetobacter baumannii.对黏菌素的再致敏导致鲍曼不动杆菌的黏附、血清抗性和 ompW 迅速而稳定的恢复。
PLoS One. 2024 Aug 28;19(8):e0309307. doi: 10.1371/journal.pone.0309307. eCollection 2024.
2019 年与 33 种细菌病原体相关的全球死亡率:2019 年全球疾病负担研究的系统分析。
Lancet. 2022 Dec 17;400(10369):2221-2248. doi: 10.1016/S0140-6736(22)02185-7. Epub 2022 Nov 21.
4
The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis.2019 年世卫组织欧洲区域细菌对抗菌药物耐药性的负担:跨国系统分析。
Lancet Public Health. 2022 Nov;7(11):e897-e913. doi: 10.1016/S2468-2667(22)00225-0. Epub 2022 Oct 14.
5
Rationale and guidance for strengthening infection prevention and control measures and antimicrobial stewardship programs in Bangladesh: a study protocol.强化孟加拉国感染预防与控制措施及抗菌药物管理项目的理由与指导:一项研究方案。
BMC Health Serv Res. 2022 Oct 7;22(1):1239. doi: 10.1186/s12913-022-08603-0.
6
Genomic Analysis of Isolates Carrying OXA-23 and OXA-58 Genes from Animals Reveals ST1 and ST25 as Major Clonal Lineages.对携带OXA - 23和OXA - 58基因的动物分离株进行基因组分析,结果显示ST1和ST25是主要的克隆谱系。
Antibiotics (Basel). 2022 Aug 3;11(8):1045. doi: 10.3390/antibiotics11081045.
7
Reduced Virulence and Enhanced Host Adaption during Antibiotics Therapy: a Story of a Within-Host Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 11 Evolution in a Patient with a Serious Scrotal Abscess.抗生素治疗期间毒力降低和宿主适应性增强:一名严重阴囊脓肿患者体内碳青霉烯类耐药肺炎克雷伯菌 11 型序列的故事
mSystems. 2022 Apr 26;7(2):e0134221. doi: 10.1128/msystems.01342-21. Epub 2022 Mar 1.
8
Infection control measures to stop the spread of sequence type 15 OXA-23-producing Acinetobacter baumannii in a Swedish Burn Center.在瑞典烧伤中心采取感染控制措施以阻止 15 型 OXA-23 型产碳青霉烯酶鲍曼不动杆菌的传播。
Burns. 2022 Dec;48(8):1940-1949. doi: 10.1016/j.burns.2022.01.018. Epub 2022 Jan 29.
9
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine).欧洲临床微生物学和传染病学会(ESCMID)治疗多重耐药革兰氏阴性杆菌感染的指南(由欧洲重症监护医学学会认可)。
Clin Microbiol Infect. 2022 Apr;28(4):521-547. doi: 10.1016/j.cmi.2021.11.025. Epub 2021 Dec 16.
10
Impact of carbapenem resistance on mortality in patients infected with : a systematic review and meta-analysis.碳青霉烯类耐药对感染患者死亡率的影响:系统评价和荟萃分析。
BMJ Open. 2021 Dec 14;11(12):e054971. doi: 10.1136/bmjopen-2021-054971.